Dr. Stanley is the inventor/co-inventor of >40 published patents in the fields of in vitro diagnostics, medical devices and drug discovery. He has developed assays to detect and quantity brain-derived oligomeric and aggregated protein biomarkers in the blood including amyloid-ß and α-synuclein.
His current focus is on the diagnosis (and misdiagnosis) of Alzheimer’s Disease, Parkinson’s Disease and other Lewy Body disorders, such as Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA). Dr. Stanley is networked with a number of partners including the Universities of Liverpool, Lancaster and Newcastle.
Dr. Stanley was a co-founder of CynapseDx and Circular1 Health.